Nature Methods has crowned spatially resolved transcriptomics Method of the Year 2020. In conjunction to that, Spatialomics@LU was featured on the LTH website.
Doctor Magnus Jakobsson has received a 2 million SEK grant from Mats Paulsson’s Research, Innovation and Societal Development fund for the development of new diagnostics for ovarian cancer. The study aims at developing a new...
Doctor Anna Sandström Gerdtsson has received 2 million SEK from the Cancera foundation for Spatial analysis of immune infiltration for individualized treatment of ovarian cancer. The study, which will be one of the first...
Doctor Magnus Jakobsson will present his work 28.10.2020 on the enzymology and clinical relevance of post‑translational modifications (PTM) of the universally conserved protein Hsp70. His work has uncovered the human enzyme...
Doctor Kathrin Zeller was 28.8.2020 appointed as Associate Professor in Immunotechnology by the Faculty of Engineering at Lund University. Her research focuses on in vitro models to investigate human...
Aastha Sobti, one of the CanFaster Ph.D. students at the Department of Immunotechnology, represents cancer research at the EU online exhibition Science is Wonderful! Her work on tonsil cancer was selected as one of the forty...
Professor Carl Borrebaeck of the Department of Immunotechnology and CREATE Health, a Strategic Center for Translational Cancer Research, has, as an expert scientist member of the EU Reference Laboratory for Alternatives to...
Magnus Jakobsson has received a 400 k SEK research grant from the Crafoord Foundation to develop new mass spectrometry-based methods for the analysis of protein post-translational modifications.
A research team headed by Prof. Mats Ohlin of the Dept. of Immunotechnology has received funding for studies and development of human antibodies specific for the SARS-CoV-2 virus, the virus that cause COVID-19. The collaborative...
Antibody technology and phenotypic discovery
Professor Sara Ek, Assoc Prof Kristina Lundberg, and Dr. Ulrika Axelsson, has been awarded funding’s from Cancera foundation.
Professor Sara Ek, received 2 million SEK for a project dedicated to early detection of lung cancer. The aim of the project is to develop non-invasive, specific and cost-effective diagnostic tools that can complement current screening tools that will aid in an early discovery of lung cancer.
Assoc Prof Kristina Lundberg, received 2 million SEK to identifying and characterizing new types of immune cells in solid tumors. The project will develop new ways to kick-start an immune response directed against the tumor cells. In this way, we can enable more patients to benefit from the powerful and long-lasting effects of this new type of drug.
Dr. Ulrika Axelsson received 2 million SEk for the project “The Molecular Fingerprint of Psychological Resilience”. The aim of the project is to identify a biomolecular signature that correlates with breast cancer patient’s psychological resilience. This will open up completely new strategies for cancer treatments.
The Department of immunotechnology, with Sofia Waldermarson, Sara EK and Fredrik Levander as the main applicants, has received SEK 1 million from Medicon Village owner foundation, Mats Paulssons Research, Innovation and Societal Development fund, SEK 1 million from the “Stiftelsen Stefan Paulssons cancerfond” and SEK 4 million from LTH for a new liquid chromatography (LC) mass spectrometry (MS) system.
This joint funding of a new mass spectrometer will enable researchers at the Department of Immuntechnology, as well as researchers at other departments at Lund University and members of Medicon Village to accelerate their discoveries of biomarkers for disease.
With this new much more sensitive MS system, researchers will be able to detect low abundant proteins in clinical samples, such as plasma and tumour biopsies. This MS equipment also uses smaller samples volumes, saving clinical material for other analysis methods. The investment in this new equipment will also enable new collaborations between industry and academia at Medicon Village.
Malin Lindstedt, Professor of Immunotechnology, is the second prize winner of the Foundation for Strategic Research Award for Researchers. The prize goes to the researcher who showed his greatest commitment and had the highest innovation lelvel in their research.
Malin Lindstedt has developed a series of tests under the name GARD, including "GARDpotency", which is used to predict the level of allergenicity for chemicals. This is of great importance for risk assessment of chemicals in, for example, the cosmetics industry. Malin research is behind seven patents and she is one of the founders of the company SenzaGen AB. The company currently has 14 employees and has also established a subsidiary in the US to reach the US market.
Malin Lindstedt, Professor of Immunotechnology at Lund University, has been awarded the New Thinker Award and SEK 400,000 from the Swedish Fund for Research Without Animal Experiments.
Professor Malin Lindstedt is awarded the prize for her work "with advanced methods continuing to reduce and replace the use of animals in risk assessment of chemicals and consumer products".
Carl Borrebaeck, Professor at Department of immunotechnology, has been granted the prestigious BiotechBuilders Award for his pioneering medical research and role as entrepreneur within Life Science as co-founder to SenzaGen, Immunovia, Alligator Bioscience and BioInvent.
The award was given at the annual BiotechBuilders event in Stockholm the 28th of August 2017. Through his commitment in SenzaGen, Carl Borrebaeck has contributed to the development of GARD – a gene based test for evaluation of chemical substances with allergenic properties, which reduce the need for animal testing.
Carl Borrebaeck received the BiotechBuilders Award with the motivation that he is a successful multi-entrepreneur who has contributed to the creation of numerous new life science companies, including Alligator Bioscience, Immunovia, BioInvent and SenzaGen. Also, his efforts in building scientific networks, among others Medicon Village, NOME (Nordic Mentor Network for Entrepreneurship) and Cancer Crosslink Conference, his position as a successful ”biotech builder“ makes him a valued representative figure for the Swedish Life Science industry.
Dr. Kristina Lundberg was appointed Associate Professor (docent) in Immunotechnology at Lund University.
The Call for the Canfaster is now open for applications.
Prof. Sara Ek of the Dept. of Immunotechnology heads a recently granted project entitled The translational cancer faster forward doctoral programme - CanFaster that received €1.6 M to partly fund 16 PhD students through the Marie Sklodowska-Curie action Co-funding of regional, national and international programmes (COFUND).
Dr. Sofia Waldemarson was appointed Associate Professor (docent in Swedish) in Immunotechnology at Lund University.
Professor Sara Ek of the Deptartment of Immunotechnology was awarded a grant from Cancerfonden ”Molekylära undersökningar av primära, resistenta och återfallstumörer hos patienter med mantelcellslymfom samt utveckling av kliniska verktyg för behandlingsval”
Prof. Mats Ohlin of the Dept. of Immunotechnology was awarded a grant from the Swedish Research Council for a project entitled "Molecular and functional analysis of IgE in allergy".
Malin Lindstedt was appointed professor of Immunotechnology at Lund University.
The Swedish Foundation for Strategic Environmental Research (MISTRA) will fund a second phase of the Mistra Biotech program. The program is hosted by the Swedish University of Agricultural Sciences and deeply involves Assoc Prof. Fredrik Levander of the Dept. of Immunotechnology.
Researchers in Stockholm, Uppsala, Linköping and Lund, including Professor Carl Borrebaeck of the Dept. of Immunotechnology today argued in favor of more increased funding for development of personalized medicine in Sweden. Read more about the discussion here.
Professor Sara Ek today took office as Department Head of the Department of Immunotechnology.
MSc Andy Forreryd of the Dept. of Immunotechnology won 4500 sek for best free oral presentatio at the SSCT-Swetox workshop with his presentation entitled Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature.
Rogosin Institute (New York, NY, USA) has signed an agreement with MAD for Cancer, a program headed by Prof. Carl Borrebaeck of the Dept. of Immuntechnology, to fund research Prof. Peter James of the Dept. of Immunotechnology.
Sara Ek was appointed professor of Immunotechnology at Lund University. Congratulations!
The European Spallation Source (ESS) today announced its first successful user collaboration for protein structure determination using neutron crystallography, carried out between Prof. Mats Ohlin of the Dept. of Immunotechnology and Dr. Zoë Fisher of ESS. The structure, which represents the first neutron crystal structure of a member of the large set of carbohydrate bindning modules (CBM) in complex with its carbohydrat ligand, has subsequently been published.
Andy Forreryd of the Dept. of Immunotechnology won a "Best Abstract Presentation Price" at the Oral Abstract session entitled Risk factors and biomarkers in occupational allergy held at EAACI 2015 in Barcelona. Andy's contribution was entitled Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature.
Prof. Mats Ohlin was today awarded a grant from the National Institute of Health through a project entitled Antigenic determinants of asthma-associated allergens for design of immunotherapy headed by Dr. Anna Pomés (INDOOR Biotechnologies Inc.).
Prof. Christer Wingren was awarded the distinction of Excellent Teaching Practitioner by the Lund School of Technology and he was accepted as member of the School's Pedagogic Academy.
Prof. Mats Ohlin was granted 2.5 MSEK by the Swedish Foundation for Strategic Research to support an industrial PhD student program entitled Target and antibody drug discovery in cancer in collaboration with BioInvent Int. AB.
Prof. Peter James was awarded 3.2 MSEK by the Swedish Research Council for a project entitled Analysis of post-translational modifications of membrane proteins.
Assoc. Prof. Malin Lindstedt was awarded 2.4 MSEK by the Swedish Research Council for a project entitled Vidareutveckling av GARD, ett alternativt cell-baserat test, med fokus på prediktion av irriterande substanser och potens av hudsensibiliserande kemikalier.
The Faculty of Technology at Lund University will fund a postdoctoral position within the area of RNA sequencing-assisted quantitative proteomics. The project will be hosted in the computational proteomics group headed by Assoc. Prof. Fredrik Levander.
Assoc. Prof. Malin Lindstedt of the Dept. of Immunotechnology was today awarded a grant of 6 MSEK from the Swedish Foundation for Strategic Research for a project entitled Prediction of sensibilisation by a cell-based assay system.
Dr. Mattias Levin of the Dept. of Immunotechnology today won the prize for best poster in the Allergic immune responses session at the 2014 European Academy of Allergy and Clinical Immunology Congress in Copenhagen. The titel of his work was Genetically restricted local IgE repertoires from nasal tissue of allergic donors target multiple epitopes on Bet v 1.
Dr. Kristina Lundberg of the Dept. of Immunotechnology today won the prize for best poster in the Immunotherapies & miscellaneous session at the 2014 European Academy of Allergy and Clinical Immunology Congress in Copenhagen. The titel of her work was Expression of allergy-associated C-type lectin receptors by DC subsets is modified by allergen-specific immunotherapy.
Christer Wingren was appointed Professor of Immunotechnology at Lund University. Congratulations!
The Lund University Cancer Center seminar series that aims at facilitating cancer research activities at Lund University and beyond kicks off today. During spring semester it will among others feature presentations by Christer Wingren, Peter James and Carl Borrebaeck from the Department of Immunotechnology.
Assoc. Prof. Malin Lindstedt has been awarded 2 MSEK from AFA Försäkring for a project entitled New test system for sensitizing chemicals.
Senior investigators at the Dept. of Immunotechnology presented their research at the Cancer Research Open House day arranged to present cancer research activities within Lund University departments located at Medicon Village.
Assoc. Prof. Sara Ek was awarded a grant from the Swedish Cancer Society for a project entitled "Beyond SOX11 – biological insight and development of a primary cell-based method for screeing of new pharmaceuticals targeting mantle cell lymphoma".
Assoc. Prof Christer Wingren has been granted support (5 MSEK) by the Swedish Research Council for a project entitled "Molecular profiling of systemic lupus erythematosus for better differential diagnosis and prognosis".
A European FP7 research grant has been awarded to a consortium that includes Prof. Peter James of the Dept. of Immunotechnology. The reBIRTH (Brain Imaging Return To Health) consortium is a Marie Curie Initial Training Network that gathers experts on molecular mechanisms of age-associated pathologies including neurodegeneration and depression. The group consists of seven universities, two private companies and one non-profit research organisation from 7 European countries. They work together to identify stress-regulated molecules provoking neuronal death and hindering neurogenesis, and monitor the consequences of these processes in human brain using advanced imaging techniques. Prof. James receives 6.4 MSEK and will be taking on three PhD students during the next three months.
The Department of Immunotechnology is moving to a new site! By the end of May, 2013 you will find us at Medicon Village (Building 406), Scheelevägen 2, S-223 63 Lund, Sweden.
Postal address: Dept. of Immunotechnology, Lund University, Medicon Village (Building 406), S-223 81 LUND, Sweden
Dr. Johan Malmström was appointed Assoc. Prof. (docent) in Immunotechnology.
Dr. Johan Malmström of the Dept. of Immunotechlogy was awarded a Wallenberg Academy Fellow grant (7.5 MSEK), a support form that provides long-term funding and enables the best researchers to focus their attention on their research, by the Knut and Alice Wallenberg Foundation.
The Department was granted support (a total of 9 MSEK) for four research projects by the Swedish Research Council:
Prof. Carl Borrebaeck of the Dept. of Immunotechnology has been awarded the Royal Swedish Academy of Engineering Sciences' Gold Medal for his fundamental and pioneering research in applied immunology.
Prof. Carl Borrebaeck of the Dept. of Immunotechnology has been granted the annual reward by the independent Research!Sweden (Forska!Sverige) Foundation for his research in medicine and his entrepreneurship.
Dr. Johan Malmström has received an ERC starting grant amounting to 1.5 million € from the European Science Council for his proteomics research on Streptococci in terms of a project entitled "In vivo pathogen profiling using selected reaction monitoring".
Petter Carlsson won the 1st Traditional Immunotechnology Badminton Tournament.
Dr. Anders Carlsson of the Dept. of Immunotechnology was awarded the Gina Prize for the best clinical/translational research article published during 2011 within BioCARE, a strategic cancer research program run by Lund University and University of Gothenburg.
The prize was awarded for the findings reported in:
Carlsson et al. (2011) Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases PNAS 108, 14252-14257 (Abstract).
Assoc. Prof. Malin Lindstedt was awarded 2 MSEK from VINNOVA for a project to investigate a cell based assay system for prediction of allergenicity.
Prof. Mats Ohlin was awarded a grant of 4.7 MSEK for an antibody engineering project from the Swedish National Space Board.
Paolo Cinfani of the Dept. of Immunotechnology won the 2011 Create Health Science Slam with a presentation entitled: "Cancer proteomics: a racist approach".
Johan Teleman of the Dept. of Immunotechnology was awarded a price for best MSc thesis in 2011 from the Bo Rydin Foundation for Scientific Research.
Prof. Carl Borrebaeck was awarded a 9 MSEK grant from VINNOVA for the project CREATE Health - a translational cancer center.
Doc. Malin Lindstedt has been granted support (7.08 MSEK during 2012-2015) for a research project entitled "A novel test strategy for assessing sensitizing capacity of chemicals and proteins" by FORMAS.
The Department was granted support for two research projects by the Swedish Research Council:
M.Sc. Henrik Johansson and M.Sc. Mattias Levin, doctoral students at the Department of Immunotechnology, were both awarded with presentation prizes at the 30th Congress of the European Academy of Allergy and Clinical Immunology held in Istanbul, Turkey.
Dr. Kristina Lundberg received a grant of 1 MSEK for a project entitled ”Development of effective treatment strategies in allergy" from Signhild Engkvist Stiftelse
Dr. Elin Gustavsson, a former PhD student at the Dept. of Immunotechnology, was awarded a price for best thesis conducted within the framework of the CREATE Health strategic center for translational cancer research during 2009-2010.
The Breast Cancer Initiative, a part of the interdisciplinary cancer centre Create Health headed by Prof. Carl Borrebaeck of the Dept. of Immunotechnology, was awarded 25 MSEK from the Swedish innovation agency Vinnova.
Dr. Peter Ellmark was appointed Assoc. Prof. (docent) in Immunotechnology.
Dr. Johan Malmström of the Dept. of Immunotechnology has been awarded 10 MSEK by the Swedish Foundation for Strategic Research as part of their Future Research Leaders programme for his research on virulence mechanisms in Streptococci.
Dr. Malin Lindstedt, Dr. Kristina Lundberg, M.Sc. Henrik Johansson, M.Sc. Anna Sandström och M.Sc. Mattias Levin of the Dept. of Immunotechnology were awarded 129 kSEK in travel grants from the Faculty of Engineering at Lund University.
The Department was granted support for two research projects by the Swedish Research Council:
The Department celebrated the
20th anniversary of the inauguration of Immunotechnology at Lund University.
Dr. Christer Wingren of the Dept. of Immunotechnology is a partner in the new Phast-ID project supported by a grant from the EU 7th framework programme that will develop a photonic crystal-based disposable biosensor for use in point-of-care diagnostic applications.
Johan Malmström at the Dept. of Immunotechnology has been granted 3.4 MSEK from the Crafoord Foundation.
The EU FP7-funded collaborative project AFFINOMICS - Protein Binders for Characterization of Human Proteome Function: Generation, Validation, Application commenced its operation. The Department of Immunotechnology is one of 15 partners from Sweden, Switzerland, Denmark, Finland, Germany, Italy, UK and Belgium.
Lund University and the Faculty of Engineering granted the Dept. of Immunotechnology funding for a postdoctoral position that is to be held by Dr. Kristina Lundberg.
Dr. Fredrik Levander has been appointed Associate Professor (docent) at the Department of Immunotechnology.
BioCARE, a center within the Swedish Research Council's effort to support strategic research areas, has been inaugurated. Prof. Carl Borrebaeck, the head of the Dept. of Immunotechnology, is one of 10 principal investigators active within this center. It will focus its activities to the field of biomarkers in cancer medicine.
Assoc. Prof. Sara Ek was awarded a grant (1 MSEK) from Stiftelsen Olle Engkvist Byggmästare for a project entitled "Development of therapeutic modalities based on novel transcription factors, including Sox 11".
Dr. Fredrik Levander of the Dept. of Immunotechnology is one of three principal investigators in a concortium (lead by Professor Erik Andreasson at the Swedish University of Agricultural Sciences) that has been awarded a framework project grant amounting to 20 MSEK from the Swedish Foundation for Strategic Research to investigate late blight disease in potato.
Dr. Malin Lindstedt was granted support for a research project on alternative methods that do not require laboratory animals for allergen testing by the Swedish Research Council.
Dr. Fredrik Levander has been appointed to coordinate proteomics data handling on a nation-wide level within the Bioinformatics Infrastructure for Life Sciences (BILS).
A consortium, which includes the Dept. of Immunotechnology, has been recommended to receive 64 MSEK during 2010-2014, for a project entitled "BioCARE - Biomarkers in Cancer Medicine Improving Health Care, Education and Innovation" as part of the government's allocation of resources to strategic research areas.
Prof. Carl Boorebaeck has received a grant (5 MSEK) from Vinnova to develop an affinity proteomics platform into a discovery tool
Dr. Malin Lindstedt was appointed Assoc. Prof. (docent) in Immunotechnology.
Dr. Sara Ek was appointed Assoc. Prof. (docent) in Immunotechnology.
The strategic translational research centre CREATE Health, administered by the Department of Immunotechnology, received 10 MSEK as additional funding for its final 2 years.
The Department of Immunotechnology is expanding. Mattias Levin, Frida Pauly, Linn Petersson, Zahra El-Schish and Marianne Sandin have therefore recently joined the department.
The head of the Dept. of Immunotechnology, Prof. Carl Borrebaeck, was awarded the AkzoNobel Science Award Sweden 2009 for his groundbreaking translational research and its transfer into practical use.
The head of the Dept. of Immunotechnology, Prof. Carl Borrebaeck, was appointed Assistant Vice-Chancellor of Lund University. He will focus on the University's innovation strategies.
The Department was granted support for a research project by the Swedish Cancer Society
The Department was granted support for several research projects by the Swedish Research Council:
The Department of Immunotechnology's research has been assessed as being "Excellent-Outstanding" in the University's research quality assessment programme RQ08.
Dr Sara Ek and Prof Carl Borrebaeck received a grant from the Leukemia & Lymphoma Society for a study of mantle cell lymphoma.
Researchers at the Department were granted postdoctoral research grants by the Swedish Research Council
Prof. Mats Ohlin was awarded the distinction of Excellent Teaching Practitioner by the Lund School of Technology and he was accepted as member of the School's Pedagogic Academy.
Dr. Christer Wingren received a grant from Vinnova to develop a microchip technology platform for cancer diagnosis.
The Department was granted a 2 year postdoctoral grant for Dr. Helena Persson from the Lund School of Technology.
The Department was granted support for several research projects by the Swedish Research Council:
Dr. Malin Lindstedt and Prof. Carl Borrebaeck were awarded a grant from Vinnova for a project entitled "Utveckling av ny vaccinprincip baserad på intracellulär antigenfrisättning från nanopartiklar"
The Knut and Alice Wallenberg Foundation granted a consortium at Lund University headed by the Department of Immunotechnology 25 MSEK to fund acquisition of equipment for use in genomic and proteomic studies of cancer.
The Dept. of Immunotechnology was formed after a merger of the Division of Immunotechnology (formerly at the Department of Chemistry) and the Division of Protein Technology (formerly at the Department of Electrical Measurements).
The Divisions of Immunotechnology and Protein Technology moved into new research facities at the Biomedical Centre